Diabeloop safely automates and personalizes the treatment of Type 1 diabetes

DBLG1 is a self-learning algorithm that automates and personalizes the treatment of Type 1 diabetes. The therapeutic artificial intelligence contributes to reduce the heavy mental burden associated with this chronic condition.

Automated insulin delivery thanks to therapeutic artificial intelligence

The DBLG1 algorithm developed by Diabeloop is hosted on a dedicated handset and acts as a user interface. It is connected to a continuous glucose monitoring (CGM) and an insulin pump. 

How does it work? Every 5 minutes, a glucose measurement is transmitted via Bluetooth® technology to the handset. The DBLG1 artificial intelligence analyzes the data in real time, while considering the patient’s physiology, history and data entries (meals or exercise) to determine the correct dose of insulin to administer. That is what we call a hybrid closed-loop system.